Cargando…
Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy
Characterizing neutralizing antibody (NAb) responses in individuals infected with diverse HIV-1 strains is necessary to reveal the novel targets for regional preventive and therapeutic strategies development. We evaluated the prevalence, breadth, and potency of NAb responses in 98 CRF07_BC-infected...
Autores principales: | Hu, Xintao, Hu, Yuanyuan, Zhao, Chunhong, Gao, Hongmei, Greene, Kelli M., Ren, Li, Ma, Liying, Ruan, Yuhua, Sarzotti-Kelsoe, Marcella, Montefiori, David C., Hong, Kunxue, Shao, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384219/ https://www.ncbi.nlm.nih.gov/pubmed/28387330 http://dx.doi.org/10.1038/srep46308 |
Ejemplares similares
-
Geographic origin and evolutionary history of China’s two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC
por: Feng, Yi, et al.
Publicado: (2016) -
Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time
por: Wang, Lijie, et al.
Publicado: (2022) -
Construction and Characterization of Highly Infectious Full-Length Molecular Clones of a HIV-1 CRF07_BC Isolate from Xinjiang, China
por: Wang, Zheng, et al.
Publicado: (2013) -
Susceptibility of HIV-1 Subtypes B′, CRF07_BC and CRF01_AE that Are Predominantly Circulating in China to HIV-1 Entry Inhibitors
por: Yu, Xiaoling, et al.
Publicado: (2011) -
CRF07_BC is associated with slow HIV disease progression in Chinese patients
por: Ye, Jingrong, et al.
Publicado: (2022)